ExPASy logo ExPASy Home page Site Map Search ExPASy Contact us Swiss-Prot
Notice: This page will be replaced with www.uniprot.org. Please send us your feedback!
Search for

UniProtKB/Swiss-Prot entry P12259


[Entry info] [Name and origin] [References] [Comments] [Cross-references] [Keywords] [Features] [Sequence] [Tools]

Note: most headings are clickable, even if they don't appear as links. They link to the user manual or other documents.
Entry information
Entry name FA5_HUMAN
Primary accession number P12259
Secondary accession numbers Q14285 Q6UPU6
Integrated into Swiss-Prot on October 1, 1989
Sequence was last modified on March 1, 2005 (Sequence version 3)
Annotations were last modified on    July 22, 2008 (Entry version 119)
Name and origin of the protein
Protein name Coagulation factor V [Precursor]
Synonym Activated protein C cofactor
Contains Coagulation factor V heavy chain
Coagulation factor V light chain
Gene name
Name: F5
From
Homo sapiens (Human) [TaxID: 9606] 
Taxonomy Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae; Homo.
Protein existence 1: Evidence at protein level;
References
[1]
NUCLEOTIDE SEQUENCE [MRNA], AND VARIANTS ARG-858; ARG-865 AND GLU-925.
PubMed=3110773 [NCBI, ExPASy, EBI, Israel, Japan]
Jenny R.J., Pittman D.D., Toole J.J., Kriz R.W., Aldape R.A., Hewick R.M., Kaufman R.J., Mann K.G.;
"Complete cDNA and derived amino acid sequence of human factor V.";
Proc. Natl. Acad. Sci. U.S.A. 84:4846-4850(1987).
[2]
NUCLEOTIDE SEQUENCE [GENOMIC DNA], AND VARIANT MET-1764.
DOI=10.1021/bi00130a007; PubMed=1567832 [NCBI, ExPASy, EBI, Israel, Japan]
Cripe L.D., Moore K.D., Kane W.H.;
"Structure of the gene for human coagulation factor V.";
Biochemistry 31:3777-3785(1992).
[3]
NUCLEOTIDE SEQUENCE [GENOMIC DNA], AND VARIANTS SER-15; HIS-107; THR-413; LYS-513; GLN-534; SER-809; THR-817; ARG-858; ARG-865; SER-915; GLU-925; SER-969; LEU-980; GLN-1146; ILE-1285; SER-1404; ALA-1530; MET-1764 AND THR-2148.
SeattleSNPs program for genomic applications;
Submitted (AUG-2003) to the EMBL/GenBank/DDBJ databases.
[4]
NUCLEOTIDE SEQUENCE [MRNA] OF 1-1600, AND VARIANTS ARG-858; ARG-865; GLU-925 AND ILE-1285.
DOI=10.1021/bi00394a033; PubMed=2827731 [NCBI, ExPASy, EBI, Israel, Japan]
Kane W.H., Ichinose A., Hagen F.S., Davie E.W.;
"Cloning of cDNAs coding for the heavy chain region and connecting region of human factor V, a blood coagulation factor with four types of internal repeats.";
Biochemistry 26:6508-6514(1987).
[5]
NUCLEOTIDE SEQUENCE [MRNA] OF 1188-1215 AND 1315-2224.
PubMed=3092220 [NCBI, ExPASy, EBI, Israel, Japan]
Kane W.H., Davie E.W.;
"Cloning of a cDNA coding for human factor V, a blood coagulation factor homologous to factor VIII and ceruloplasmin.";
Proc. Natl. Acad. Sci. U.S.A. 83:6800-6804(1986).
[6]
PARTIAL NUCLEOTIDE SEQUENCE [MRNA].
TISSUE=Fibroblast;
PubMed=8454869 [NCBI, ExPASy, EBI, Israel, Japan]
Shen N.L.L., Fan S.-T., Pyati J., Graff R., Lapolla R.J., Edgington T.S.;
"The serine protease cofactor factor V is synthesized by lymphocytes.";
J. Immunol. 150:2992-3001(1993).
[7]
COPPER BINDING.
PubMed=6490642 [NCBI, ExPASy, EBI, Israel, Japan]
Mann K.G., Lawler C.M., Vehar G.A., Church W.R.;
"Coagulation Factor V contains copper ion.";
J. Biol. Chem. 259:12949-12951(1984).
[8]
SULFATION.
DOI=10.1021/bi00188a026; PubMed=8204629 [NCBI, ExPASy, EBI, Israel, Japan]
Pittman D.D., Tomkinson K.N., Michnick D., Selighsohn U., Kaufman R.J.;
"Posttranslational sulfation of factor V is required for efficient thrombin cleavage and activation and for full procoagulant activity.";
Biochemistry 33:6952-6959(1994).
[9]
SULFATION.
PubMed=2168225 [NCBI, ExPASy, EBI, Israel, Japan]
Hortin G.L.;
"Sulfation of tyrosine residues in coagulation factor V.";
Blood 76:946-952(1990).
[10]
GLYCOSYLATION [LARGE SCALE ANALYSIS] AT ASN-297; ASN-460; ASN-821; ASN-977 AND ASN-1559, AND MASS SPECTROMETRY.
TISSUE=Plasma;
DOI=10.1021/pr0502065; PubMed=16335952 [NCBI, ExPASy, EBI, Israel, Japan]
Liu T., Qian W.-J., Gritsenko M.A., Camp D.G. II, Monroe M.E., Moore R.J., Smith R.D.;
"Human plasma N-glycoproteome analysis by immunoaffinity subtraction, hydrazide chemistry, and mass spectrometry.";
J. Proteome Res. 4:2070-2080(2005).
[11]
GLYCOSYLATION [LARGE SCALE ANALYSIS] AT ASN-297, AND MASS SPECTROMETRY.
TISSUE=Platelet;
DOI=10.1074/mcp.M500324-MCP200; PubMed=16263699 [NCBI, ExPASy, EBI, Israel, Japan]
Lewandrowski U., Moebius J., Walter U., Sickmann A.;
"Elucidation of N-glycosylation sites on human platelet proteins: a glycoproteomic approach.";
Mol. Cell. Proteomics 5:226-233(2006).
[12]
PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-1150, AND MASS SPECTROMETRY.
TISSUE=Platelet;
DOI=10.1021/pr0704130; PubMed=18088087 [NCBI, ExPASy, EBI, Israel, Japan]
Zahedi R.P., Lewandrowski U., Wiesner J., Wortelkamp S., Moebius J., Schuetz C., Walter U., Gambaryan S., Sickmann A.;
"Phosphoproteome of resting human platelets.";
J. Proteome Res. 7:526-534(2008).
[13]
X-RAY CRYSTALLOGRAPHY (1.9 ANGSTROMS) OF 2065-2224.
DOI=10.1038/46594; PubMed=10586886 [NCBI, ExPASy, EBI, Israel, Japan]
Macedo-Ribeiro S., Bode W., Huber R., Quinn-Allen M.A., Kim S.W., Ortel T.L., Bourenkov G.P., Bartunik H.D., Stubbs M.T., Kane W.H., Fuentes-Prior P.;
"Crystal structures of the membrane-binding C2 domain of human coagulation factor V.";
Nature 402:434-439(1999).
[14]
VARIANT MET-1764.
PubMed=7874144 [NCBI, ExPASy, EBI, Israel, Japan]
Bayston T.A., Ireland H., Olds R.J., Thein S.L., Lane D.A.;
"A polymorphism in the human coagulation factor V gene.";
Hum. Mol. Genet. 3:2085-2085(1994).
[15]
VARIANT GLN-534.
DOI=10.1038/369064a0; PubMed=8164741 [NCBI, ExPASy, EBI, Israel, Japan]
Bertina R.M., Koeleman B.P.C., Koster T., Rosendaal F.R., Dirven R.J., de Ronde H., van der Velden P.A., Reitsma P.H.;
"Mutation in blood coagulation factor V associated with resistance to activated protein C.";
Nature 369:64-67(1994).
[16]
VARIANTS ILE-1285 AND ARG-1327.
PubMed=8713778 [NCBI, ExPASy, EBI, Israel, Japan]
Lunghi B., Iacoviello L., Gemmati D., Dilasio M.G., Castoldi E., Pinotti M., Castaman G., Redaelli R., Mariani G., Marchetti G., Bernardi F.;
"Detection of new polymorphic markers in the factor V gene: association with factor V levels in plasma.";
Thromb. Haemost. 75:45-48(1996).
[17]
ASSOCIATION OF VARIANT GLN-534 WITH SUSCEPTIBILITY TO BUDD-CHIARI SYNDROME.
PubMed=9245936 [NCBI, ExPASy, EBI, Israel, Japan]
Mahmoud A.E.A., Elias E., Beauchamp N., Wilde J.T.;
"Prevalence of the factor V Leiden mutation in hepatic and portal vein thrombosis.";
Gut 40:798-800(1997).
[18]
VARIANT THROMBOPHILIA GLY-334, AND VARIANT LYS-513.
PubMed=9454741 [NCBI, ExPASy, EBI, Israel, Japan]
Chan W.P., Lee C.K., Kwong Y.L., Lam C.K., Liang R.;
"A novel mutation of Arg306 of factor V gene in Hong Kong Chinese.";
Blood 91:1135-1139(1998).
[19]
VARIANT APCR THR-334.
PubMed=9454742 [NCBI, ExPASy, EBI, Israel, Japan]
Williamson D., Brown K., Luddington R., Baglin C., Baglin T.;
"Factor V Cambridge: a new mutation (Arg306-to-Thr) associated with resistance to activated protein C.";
Blood 91:1140-1144(1998).
[20]
VARIANT THROMBOPHILIA GLY-334.
PubMed=9746807 [NCBI, ExPASy, EBI, Israel, Japan]
Liang R., Lee C.K., Wat M.S., Kwong Y.L., Lam C.K., Liu H.W.;
"Clinical significance of Arg306 mutations of factor V gene.";
Blood 92:2599-2600(1998).
[21]
VARIANTS HIS-107; THR-413; LYS-513; GLN-534; SER-809; THR-817; ARG-858; ARG-865; GLU-925; GLN-1146; ALA-1530; SER-1685; VAL-1749; MET-1764; ILE-1820 AND GLY-2222.
DOI=10.1038/10290; PubMed=10391209 [NCBI, ExPASy, EBI, Israel, Japan]
Cargill M., Altshuler D., Ireland J., Sklar P., Ardlie K., Patil N., Shaw N., Lane C.R., Lim E.P., Kalyanaraman N., Nemesh J., Ziaugra L., Friedland L., Rolfe A., Warrington J., Lipshutz R., Daley G.Q., Lander E.S.;
"Characterization of single-nucleotide polymorphisms in coding regions of human genes.";
Nat. Genet. 22:231-238(1999).
[22]
ERRATUM.
Cargill M., Altshuler D., Ireland J., Sklar P., Ardlie K., Patil N., Shaw N., Lane C.R., Lim E.P., Kalyanaraman N., Nemesh J., Ziaugra L., Friedland L., Rolfe A., Warrington J., Lipshutz R., Daley G.Q., Lander E.S.;
Nat. Genet. 23:373-373(1999).
[23]
VARIANT FACTOR V DEFICIENCY CYS-1730, AND VARIANTS GLN-534 AND ARG-1327.
PubMed=10942390 [NCBI, ExPASy, EBI, Israel, Japan]
Castoldi E., Simioni P., Kalafatis M., Lunghi B., Tormene D., Girelli D., Girolami A., Bernardi F.;
"Combinations of 4 mutations (FV R506Q, FV H1299R, FV Y1702C, PT 20210G/A) affecting the prothrombinase complex in a thrombophilic family.";
Blood 96:1443-1448(2000).
[24]
VARIANTS APCR ARG-613 AND CYS-1730.
DOI=10.1182/blood.V98.2.358; PubMed=11435304 [NCBI, ExPASy, EBI, Israel, Japan]
van Wijk R., Nieuwenhuis K., van den Berg M., Huizinga E.G., van der Meijden B.B., Kraaijenhagen R.J., van Solinge W.W.;
"Five novel mutations in the gene for human blood coagulation factor V associated with type I factor V deficiency.";
Blood 98:358-367(2001).
[25]
VARIANT APCR HIS-2102.
PubMed=11858490 [NCBI, ExPASy, EBI, Israel, Japan]
Schrijver I., Houissa-Kastally R., Jones C.D., Garcia K.C., Zehnder J.L.;
"Novel factor V C2-domain mutation (R2074H) in two families with factor V deficiency and bleeding.";
Thromb. Haemost. 87:294-299(2002).
[26]
VARIANT FACTOR V DEFICIENCY CYS-2102, AND CHARACTERIZATION OF VARIANT FACTOR V DEFICIENCY CYS-2102.
DOI=10.1182/blood-2002-06-1928; PubMed=12393490 [NCBI, ExPASy, EBI, Israel, Japan]
Duga S., Montefusco M.C., Asselta R., Malcovati M., Peyvandi F., Santagostino E., Mannucci P.M., Tenchini M.L.;
"Arg2074Cys missense mutation in the C2 domain of factor V causing moderately severe factor V deficiency: molecular characterization by expression of the recombinant protein.";
Blood 101:173-177(2003).
[27]
VARIANT THROMBOPHILIA THR-387.
DOI=10.1046/j.1365-2141.2003.04624.x; PubMed=14617013 [NCBI, ExPASy, EBI, Israel, Japan]
Mumford A.D., McVey J.H., Morse C.V., Gomez K., Steen M., Norstrom E.A., Tuddenham E.G.D., Dahlback B., Bolton-Maggs P.H.B.;
"Factor V I359T: a novel mutation associated with thrombosis and resistance to activated protein C.";
Br. J. Haematol. 123:496-501(2003).
[28]
ASSOCIATION OF VARIANT GLN-534 WITH SUSCEPTIBILITY TO ISCHEMIC STROKE.
DOI=10.1001/archneur.61.11.1652; PubMed=15534175 [NCBI, ExPASy, EBI, Israel, Japan]
Casas J.P., Hingorani A.D., Bautista L.E., Sharma P.;
"Meta-analysis of genetic studies in ischemic stroke: thirty-two genes involving approximately 18,000 cases and 58,000 controls.";
Arch. Neurol. 61:1652-1661(2004).
[29]
CHARACTERIZATION OF VARIANT THROMBOPHILIA THR-387.
DOI=10.1182/blood-2003-06-2092; PubMed=14695241 [NCBI, ExPASy, EBI, Israel, Japan]
Steen M., Norstroem E.A., Tholander A.-L., Bolton-Maggs P.H.B., Mumford A., McVey J.H., Tuddenham E.G.D., Dahlbaeck B.;
"Functional characterization of factor V-Ile359Thr: a novel mutation associated with thrombosis.";
Blood 103:3381-3387(2004).
[30]
VARIANT [LARGE SCALE ANALYSIS] ALA-775.
DOI=10.1126/science.1133427; PubMed=16959974 [NCBI, ExPASy, EBI, Israel, Japan]
Sjoeblom T., Jones S., Wood L.D., Parsons D.W., Lin J., Barber T.D., Mandelker D., Leary R.J., Ptak J., Silliman N., Szabo S., Buckhaults P., Farrell C., Meeh P., Markowitz S.D., Willis J., Dawson D., Willson J.K.V., Gazdar A.F., Hartigan J., Wu L., Liu C., Parmigiani G., Park B.H., Bachman K.E., Papadopoulos N., Vogelstein B., Kinzler K.W., Velculescu V.E.;
"The consensus coding sequences of human breast and colorectal cancers.";
Science 314:268-274(2006).
Comments
  • FUNCTION: Coagulation factor V is a cofactor that participates with factor Xa to activate prothrombin to thrombin.
  • SUBUNIT: Factor Va is composed of a heavy chain and a light chain, non-covalently bound. The interaction between the two chains is calcium-dependent.
  • SUBCELLULAR LOCATION: Secreted (By similarity).
  • DOMAIN: Domain B contains 35 x 9 AA tandem repeats, and 2 x 17 AA repeats.
  • PTM: Thrombin activates factor V proteolytically to the active cofactor, factor Va (formation of a heavy chain at the N-terminus and a light chain at the C-terminus).
  • PTM: Sulfation is required for efficient thrombin cleavage and activation and for full procoagulant activity.
  • DISEASE: Defects in F5 are the cause of factor V deficiency [MIM:227400]; also known as Owren parahemophilia. It is an hemorrhagic diastesis.
  • DISEASE: Defects in F5 are the cause of resistance to activated protein C (APCR) [MIM:188055]. APCR is a form of thrombophilia. The APCR mutation is found in about 5% of the population which suggest that a slight thrombotic tendency may confer some advantage in fetal implantation.
  • DISEASE: Defects in F5 are a cause of susceptibility to Budd-Chiari syndrome [MIM:600880]. Budd-Chiari syndrome is a spectrum of disease states, including anatomic abnormalities and hypercoagulable disorders, resulting in hepatic venous outflow occlusion. Clinical manifestations observed in the majority of patients include hepatomegaly, right upper quadrant pain, and abdominal ascites.
  • DISEASE: Defects in F5 may be a cause of susceptibility to ischemic stroke [MIM:601367]; also known as cerebrovascular accident or cerebral infarction. A stroke is an acute neurologic event leading to death of neural tissue of the brain and resulting in loss of motor, sensory and/or cognitive function. Ischemic strokes, resulting from vascular occlusion, is considered to be a highly complex disease consisting of a group of heterogeneous disorders with multiple genetic and environmental risk factors.
  • SIMILARITY: Belongs to the multicopper oxidase family.
  • SIMILARITY: Contains 3 F5/8 type A domains.
  • SIMILARITY: Contains 2 F5/8 type C domains.
  • SIMILARITY: Contains 6 plastocyanin-like domains.
  • WEB RESOURCE: Name=Wikipedia; Note=Factor V entry; URL="http://en.wikipedia.org/wiki/Factor_V";.
  • WEB RESOURCE: Name=GeneReviews; URL="http://www.genetests.org/query?gene=F5";.
  • WEB RESOURCE: Name=SeattleSNPs; URL="http://pga.gs.washington.edu/data/f5/";.
  • WEB RESOURCE: Name=SHMPD; Note=The Singapore human mutation and polymorphism database; URL="http://shmpd.bii.a-star.edu.sg/gene.php?genestart=A&genename=F5";.
Copyright
Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms. Distributed under the Creative Commons Attribution-NoDerivs License.
Cross-references
Sequence databases
EMBL
M16967; AAA52424.1; -; mRNA.[EMBL / GenBank / DDBJ] [CoDingSequence]
L32779; AAB59401.1; -; Genomic_DNA.[EMBL / GenBank / DDBJ] [CoDingSequence]
L32755; AAB59401.1; JOINED; Genomic_DNA.[EMBL / GenBank / DDBJ] [CoDingSequence]
L32756; AAB59401.1; JOINED; Genomic_DNA.[EMBL / GenBank / DDBJ] [CoDingSequence]
L32757; AAB59401.1; JOINED; Genomic_DNA.[EMBL / GenBank / DDBJ] [CoDingSequence]
L32758; AAB59401.1; JOINED; Genomic_DNA.[EMBL / GenBank / DDBJ] [CoDingSequence]
L32759; AAB59401.1; JOINED; Genomic_DNA.[EMBL / GenBank / DDBJ] [CoDingSequence]
L32760; AAB59401.1; JOINED; Genomic_DNA.[EMBL / GenBank / DDBJ] [CoDingSequence]
L32761; AAB59401.1; JOINED; Genomic_DNA.[EMBL / GenBank / DDBJ] [CoDingSequence]
L32762; AAB59401.1; JOINED; Genomic_DNA.[EMBL / GenBank / DDBJ] [CoDingSequence]
L32763; AAB59401.1; JOINED; Genomic_DNA.[EMBL / GenBank / DDBJ] [CoDingSequence]
L32764; AAB59401.1; JOINED; Genomic_DNA.[EMBL / GenBank / DDBJ] [CoDingSequence]
L32765; AAB59401.1; JOINED; Genomic_DNA.[EMBL / GenBank / DDBJ] [CoDingSequence]
L32766; AAB59401.1; JOINED; Genomic_DNA.[EMBL / GenBank / DDBJ] [CoDingSequence]
L32767; AAB59401.1; JOINED; Genomic_DNA.[EMBL / GenBank / DDBJ] [CoDingSequence]
L32768; AAB59401.1; JOINED; Genomic_DNA.[EMBL / GenBank / DDBJ] [CoDingSequence]
L32769; AAB59401.1; JOINED; Genomic_DNA.[EMBL / GenBank / DDBJ] [CoDingSequence]
L32770; AAB59401.1; JOINED; Genomic_DNA.[EMBL / GenBank / DDBJ] [CoDingSequence]
L32771; AAB59401.1; JOINED; Genomic_DNA.[EMBL / GenBank / DDBJ] [CoDingSequence]
L32772; AAB59401.1; JOINED; Genomic_DNA.[EMBL / GenBank / DDBJ] [CoDingSequence]
L32773; AAB59401.1; JOINED; Genomic_DNA.[EMBL / GenBank / DDBJ] [CoDingSequence]
L32774; AAB59401.1; JOINED; Genomic_DNA.[EMBL / GenBank / DDBJ] [CoDingSequence]
L32775; AAB59401.1; JOINED; Genomic_DNA.[EMBL / GenBank / DDBJ] [CoDingSequence]
L32776; AAB59401.1; JOINED; Genomic_DNA.[EMBL / GenBank / DDBJ] [CoDingSequence]
L32777; AAB59401.1; JOINED; Genomic_DNA.[EMBL / GenBank / DDBJ] [CoDingSequence]
L32778; AAB59401.1; JOINED; Genomic_DNA.[EMBL / GenBank / DDBJ] [CoDingSequence]
AY364535; AAQ55063.1; -; Genomic_DNA.[EMBL / GenBank / DDBJ] [CoDingSequence]
M14335; AAB59532.1; -; mRNA.[EMBL / GenBank / DDBJ] [CoDingSequence]
PIR A56172; KFHU5.
RefSeq NP_000121.2; -.
UniGene Hs.30054
3D structure databases
PDB
1CZS; X-ray; 1.90 A; A=2065-2224.[ExPASy / RCSB / EBI]
1CZT; X-ray; 1.87 A; A=2065-2224.[ExPASy / RCSB / EBI]
1CZV; X-ray; 2.40 A; A/B=2065-2224.[ExPASy / RCSB / EBI]
1FV4; Model; -; H=29-691, L=1574-2224.[ExPASy / RCSB / EBI]
1Y61; Model; -; H=29-737, L=1574-2224.[ExPASy / RCSB / EBI]
Detailed list of linked structures.
PDBsum 1CZS; -.
1CZT; -.
1CZV; -.
1FV4; -.
1Y61; -.
SMR P12259; 1575-2223.
ModBase P12259.
PTM databases
PhosphoSite P12259; -.
Enzyme and pathway databases
Reactome REACT_604; Hemostasis.
Organism-specific databases
H-InvDB HIX0028626; -.
HGNC HGNC:3542; F5.
GenAtlas F5.
HPA HPA002036; -.
MIM 188055; phenotype. [NCBI / EBI]
227400; gene+phenotype. [NCBI / EBI]
600880; phenotype. [NCBI / EBI]
601367; phenotype. [NCBI / EBI]
Orphanet 326; Factor V deficiency.
64738; Resistance to activated protein C.
PharmGKB PA24941; -.
GeneCards P12259.
Gene expression databases
ArrayExpress P12259; -.
CleanEx HS_F5; -.
GermOnline ENSG00000198734; Homo sapiens.
Ontologies
GO
GO:0005576; Cellular component: extracellular region (non-traceable author statement from UniProtKB).
GO:0005886; Cellular component: plasma membrane (inferred from experiment from Reactome).
GO:0031093; Cellular component: platelet alpha granule lumen (inferred from experiment from Reactome).
GO:0007596; Biological process: blood coagulation (traceable author statement from ProtInc).
QuickGo view.
Family and domain databases
InterPro IPR000421; Coagulation_factor_5/8-type_C.
IPR009271; Coagulation_factor_V_LSPD.
IPR011707; Cu-oxidase_3.
IPR002355; Cu_oxidase_Cu_BS.
IPR008972; Cupredoxin.
Graphical view of domain structure.
Gene3D G3DSA:2.60.40.420; Cupredoxin; 6.
Pfam PF07732; Cu-oxidase_3; 1.
PF00754; F5_F8_type_C; 2.
PF06049; LSPR; 29.
Pfam graphical view of domain structure.
SMART SM00231; FA58C; 2.
SMART graphical view of domain structure.
PROSITE PS01285; FA58C_1; 2.
PS01286; FA58C_2; 2.
PS50022; FA58C_3; 2.
PS00079; MULTICOPPER_OXIDASE1; 2.
PROSITE graphical view of domain structure (profiles).
BLOCKS P12259.
Genome annotation databases
Ensembl ENSG00000198734; Homo sapiens. [Contig view]
GeneID 2153; -.
KEGG hsa:2153; -.
Phylogenomic databases
HOVERGEN P12259; -.
Other
DrugBank DB00055; Drotrecogin alfa.
SOURCE F5; Homo sapiens.
ProtoNet P12259.
UniRef View cluster of proteins with at least 50% / 90% / 100% identity.
Keywords
3D-structure; Blood coagulation; Calcium; Copper; Disease mutation; Glycoprotein; Metal-binding; Phosphoprotein; Polymorphism; Repeat; Secreted; Signal; Sulfation; Thrombophilia; Zymogen.
Features
SEVIEWER logo Feature table viewer FT aligner logo Feature aligner
KeyFrom    To Length Description FTId
SIGNAL   1     28  28      
CHAIN   29   2224  2196     Coagulation factor V. PRO_0000002978
CHAIN   29    737  709     Coagulation factor V heavy chain. PRO_0000002979
PROPEP   738   1573  836     Activation peptide (connecting region). PRO_0000002980
CHAIN   1574   2224  651     Coagulation factor V light chain. PRO_0000002981
DOMAIN   30    329  300     F5/8 type A 1. 
DOMAIN   30    193  164     Plastocyanin-like 1. 
DOMAIN   203    329  127     Plastocyanin-like 2. 
DOMAIN   348    684  337     F5/8 type A 2. 
DOMAIN   348    526  179     Plastocyanin-like 3. 
DOMAIN   536    684  149     Plastocyanin-like 4. 
REPEAT   895    911  17     1-1. 
REPEAT   912    928  17     1-2. 
REPEAT   1185   1193  9     2-1. 
REPEAT   1194   1202  9     2-2. 
REPEAT   1203   1211  9     2-3. 
REPEAT   1212   1220  9     2-4. 
REPEAT   1221   1229  9     2-5. 
REPEAT   1230   1238  9     2-6. 
REPEAT   1239   1247  9     2-7. 
REPEAT   1248   1256  9     2-8. 
REPEAT   1257   1265  9     2-9. 
REPEAT   1266   1274  9     2-10. 
REPEAT   1275   1283  9     2-11. 
REPEAT   1284   1292  9     2-12. 
REPEAT   1293   1301  9     2-13. 
REPEAT   1302   1310  9     2-14. 
REPEAT   1311   1319  9     2-15. 
REPEAT   1320   1328  9     2-16. 
REPEAT   1329   1337  9     2-17. 
REPEAT   1338   1346  9     2-18. 
REPEAT   1347   1355  9     2-19. 
REPEAT   1356   1364  9     2-20. 
REPEAT   1365   1373  9     2-21. 
REPEAT   1374   1382  9     2-22. 
REPEAT   1383   1391  9     2-23. 
REPEAT   1392   1400  9     2-24. 
REPEAT   1401   1409  9     2-25. 
REPEAT   1410   1418  9     2-26. 
REPEAT   1419   1427  9     2-27. 
REPEAT   1428   1436  9     2-28. 
REPEAT   1437   1445  9     2-29. 
REPEAT   1446   1454  9     2-30. 
REPEAT   1455   1463  9     2-31. 
REPEAT   1464   1472  9     2-32. 
REPEAT   1473   1481  9     2-33. 
REPEAT   1482   1490  9     2-34. 
REPEAT   1493   1501  9     2-35. 
DOMAIN   1578   1907  330     F5/8 type A 3.